Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.
about
Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK miceMetformin as treatment for overweight and obese adults: a systematic reviewInsulin resistance: site of the primary defect or how the current and the emerging therapies work.Metformin-associated lactic acidosis: a rare or very rare clinical entity?Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.Effects of metformin on endothelial health and erectile dysfunction.Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosisFibrinolytic activity in Nigerian diabetics.Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study.Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction."Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity.Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes.AMP-Activated Protein Kinase Regulates Oxidative Metabolism in Caenorhabditis elegans through the NHR-49 and MDT-15 Transcriptional RegulatorsEffect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome.Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adultsMetformin: an old but still the best treatment for type 2 diabetes.AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.Metformin.Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo.Role of metformin for weight management in patients without type 2 diabetes.The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolismInsulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.Metformin therapy in diabetes: the role of cardioprotection.Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.From apelin to exercise: emerging therapies for management of hypertension in pregnancy.The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisMean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.Cardiovascular effects of oral hypoglycaemic drugs.Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin.Metabolic effects of metformin in patients with impaired glucose tolerance.Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension.Locally delivered 1% metformin gel in the treatment of smokers with chronic periodontitis: a randomized controlled clinical trial.The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus; a systematic review.
P2860
Q28204609-39EE62A1-379B-42A9-BFE1-34071B927F43Q33224084-A14C5911-6E39-4F53-B85E-0DA413D3B2ACQ33599434-9E5192A3-1687-4CB4-B2A4-20C1507394A6Q33603791-C60FAD3A-A723-4AF9-91C4-6C6AC066D5DEQ33838229-D7D850E8-B022-4334-A963-885A46AA3AAFQ33858074-C08D2993-86A2-4659-894E-14ABA97BD232Q33890190-083987FC-8693-4CE4-81F6-A5EF7F0B9EBEQ34024266-82B9C770-3720-434C-B82C-11CAD40A408CQ34166377-5ADBD514-6FFF-42E5-BFF5-55CE791FD1DBQ35114963-E5BAA843-3F99-4D7D-9333-9041B6128BAFQ35520503-E44F4341-F918-4E6B-86FC-8FD8B087722EQ35584134-4BC618AC-0F97-4E50-8D9E-279B8FD55CCBQ35599981-494EA1ED-E8A5-453C-B30A-EEB1D4FB3A35Q35612646-662B7190-2713-48DE-B7DD-00BDDE84E974Q35736638-6877C045-410A-45EF-8A01-63971CFA5D67Q35796963-E5838EF3-41BA-4315-9C39-14108ED5D3E4Q35908579-55ADDEB0-25A8-49E3-8B12-A4753F90AAA2Q36287784-F9D1F490-A79C-4EC2-A8D9-7EFC91ACB61AQ36403722-21C6A88D-22C2-45CD-B4FD-B0CC7503AB6CQ36715464-45E01087-FC2B-4FBF-AA1C-DC7285451E23Q36764442-5D9177D1-056C-41A6-9FDB-24DB4D29A65AQ37083602-A642A0CE-7E09-417A-A344-9324854D8620Q37125699-5C1C87D5-AD86-411A-A395-868A71EF4273Q37162889-B2537F93-EF88-4EAD-A357-8FCA08A001C7Q37196034-CCAB9368-15FE-42DD-ABE7-4E1F8D21A87EQ37358571-858A5078-7259-46C7-89FC-578BF7DBAC11Q37434434-44DD0DF2-D0F1-460B-9074-FC76B47E284AQ37472745-E54EF1D1-C294-463E-8A00-6E2B08BBEDC8Q38083008-6729133B-43B7-4D6F-A56B-EF7E5C80A66EQ38386992-E5A2E4DE-0205-4C5F-8189-3F6CA7A92927Q39223093-E4C11763-9B84-4299-B46E-9512C69F6E05Q41019747-EB15A6A3-227E-48C3-9CE2-07DA947E25FFQ41054147-BE343FA7-CECA-49ED-9CCF-FBA0224125A7Q41230943-93974ECC-D42F-40EF-96E8-198AABEAA7EBQ41480617-6D208F74-5ED5-48B5-A04D-AD14C1472B50Q43734822-1BD9B578-28E0-4DC9-AD25-ABF9F0984276Q43795772-ABA5E7B8-3031-40AD-A204-AA7F624144DAQ44521963-9E9974C4-C08E-4DCD-8BC6-3F2FA315EC7CQ45302135-69B82CE0-53AE-468E-8A59-42EC6148F8ADQ46055722-57234397-21D7-4B08-9FB9-8C8E1D1DE58C
P2860
Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Metformin improves glucose, li ...... in hypertensive, obese women.
@en
Metformin improves glucose, li ...... in hypertensive, obese women.
@nl
type
label
Metformin improves glucose, li ...... in hypertensive, obese women.
@en
Metformin improves glucose, li ...... in hypertensive, obese women.
@nl
prefLabel
Metformin improves glucose, li ...... in hypertensive, obese women.
@en
Metformin improves glucose, li ...... in hypertensive, obese women.
@nl
P2093
P1433
P1476
Metformin improves glucose, li ...... in hypertensive, obese women.
@en
P2093
Acampora R
Buoninconti R
D'Onofrio F
Giugliano D
Marfella R
P304
P356
10.2337/DIACARE.16.10.1387
P407
P577
1993-10-01T00:00:00Z